# Amlodipine Prevents Morning Blood Pressure Surge Study

> **NCT01030081** · PHASE4 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 510 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlodipine (Norvasc®)
- **DRUG:** Nifedipine GITS (Adalat® XL 30

## Key facts

- **NCT ID:** NCT01030081
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2014-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01030081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01030081, "Amlodipine Prevents Morning Blood Pressure Surge Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01030081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*